Keep Me Logged In
Aswath Damodaran, Professor of Finance Education at NYU Leonard N. Stern School of Business who is also known as the "Dean of Valuation," discusses Valeant Pharmaceuticals' valuation and why he thinks it is still a good investment.
Got a confidential news tip? We want to hear from you.
Sign up for free newsletters and get more CNBC delivered to your inbox
© 2019 CNBC LLC. All Rights Reserved. A Division of NBCUniversal
Data is a real-time snapshot *Data is delayed at least 15 minutes. Global Business and Financial News, Stock Quotes, and Market Data and Analysis.
Data also provided by